Keywords: claritin, generics, cut, rx, market, introduction, generic
Claritin generics "will cut US Rx market 15%"
Article | 19 August 2002
The introduction of generic forms of Schering-Plough's Claritin(loratadine) will reduce the US antihistamine market 15% over the next 10 years, and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
